BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18599028)

  • 1. Release of acetylcholinesterase (AChE) from beta-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice.
    Dinamarca MC; Arrázola M; Toledo E; Cerpa WF; Hancke J; Inestrosa NC
    Chem Biol Interact; 2008 Sep; 175(1-3):142-9. PubMed ID: 18599028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
    Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
    Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
    Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
    J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit.
    Poirier R; Wolfer DP; Welzl H; Tracy J; Galsworthy MJ; Nitsch RM; Mohajeri MH
    Neurobiol Dis; 2006 Dec; 24(3):475-83. PubMed ID: 17008108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.
    Knobloch M; Konietzko U; Krebs DC; Nitsch RM
    Neurobiol Aging; 2007 Sep; 28(9):1297-306. PubMed ID: 16876915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.
    Dinamarca MC; Cerpa W; Garrido J; Hancke JL; Inestrosa NC
    Mol Psychiatry; 2006 Nov; 11(11):1032-48. PubMed ID: 16880827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
    Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
    Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
    Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
    Philipson O; Lannfelt L; Nilsson LN
    FEBS Lett; 2009 Sep; 583(18):3021-6. PubMed ID: 19683527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.
    Onozuka H; Nakajima A; Matsuzaki K; Shin RW; Ogino K; Saigusa D; Tetsu N; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
    J Pharmacol Exp Ther; 2008 Sep; 326(3):739-44. PubMed ID: 18544674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice.
    Eckert A; Hauptmann S; Scherping I; Rhein V; Müller-Spahn F; Götz J; Müller WE
    Neurodegener Dis; 2008; 5(3-4):157-9. PubMed ID: 18322377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
    Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
    Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.
    Berson A; Knobloch M; Hanan M; Diamant S; Sharoni M; Schuppli D; Geyer BC; Ravid R; Mor TS; Nitsch RM; Soreq H
    Brain; 2008 Jan; 131(Pt 1):109-19. PubMed ID: 18056160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis.
    Gervais F; Paquette J; Morissette C; Krzywkowski P; Yu M; Azzi M; Lacombe D; Kong X; Aman A; Laurin J; Szarek WA; Tremblay P
    Neurobiol Aging; 2007 Apr; 28(4):537-47. PubMed ID: 16675063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
    Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
    J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.
    Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V
    Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice.
    Le Cudennec C; Faure A; Ly M; Delatour B
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():83-91. PubMed ID: 18184372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.